These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 108033)

  • 1. Substrate-labeled fluorescent immunoassay for phenytoin in human serum.
    Wong RC; Burd JF; Carrico RJ; Buckler RT; Thoma J; Boguslaski RC
    Clin Chem; 1979 May; 25(5):686-91. PubMed ID: 108033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of phenytoin and phenobarbital in serum or plasma by substrate-labeled fluorescent immunoassay.
    Dean KJ; Thompson SG; Burd JF; Buckler RT
    Clin Chem; 1983 Jun; 29(6):1051-6. PubMed ID: 6303626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homogeneous reactant-labeled fluorescent immunoassay for therapeutic drugs exemplified by gentamicin determination in human serum.
    Burd JF; Wong RC; Feeney JE; Carrico RJ; Boguslaski RC
    Clin Chem; 1977 Aug; 23(8):1402-8. PubMed ID: 326439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate-labeled fluorescent immunoassay for amikacin in human serum.
    Thompson SG; Burd JF
    Antimicrob Agents Chemother; 1980 Aug; 18(2):264-8. PubMed ID: 7004339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of total and free phenytoin in serum by non-isotopic immunoassays and gas chromatography.
    Külpmann WR; Gey S; Beneking M; Kohl B; Oellerich M
    J Clin Chem Clin Biochem; 1984 Nov; 22(11):773-9. PubMed ID: 6396367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate-labeled fluorescent immunoassay for phenobarbital.
    Krausz LM; Hitz JB; Buckler RT; Burd JF
    Ther Drug Monit; 1980; 2(3):261-72. PubMed ID: 7013165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of serum phenytoin determination by the substrate-labeled fluorescent immunoassay with gas chromatography, liquid chromatography, radioimmunoassay and "EMIT".
    Wong RC; George R; Yeung R; Burd JF
    Clin Chim Acta; 1980 Jan; 100(1):65-9. PubMed ID: 6985851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-labeled fluorescent immunoassay for measuring dibekacin concentrations in serum and plasma.
    Place JD; Thompson SG
    Antimicrob Agents Chemother; 1983 Aug; 24(2):240-5. PubMed ID: 6357071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homogeneous substrate-labeled fluorescent immunoassay for theophylline in serum.
    Li TM; Benovic JL; Buckler RT; Burd JF
    Clin Chem; 1981 Jan; 27(1):22-6. PubMed ID: 7449119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand displacement immunoassay--demonstration of its use for the measurement of serum phenobarbital and phenytoin.
    Hinds JA; Pincombe CF; Smith S; Duffy P
    Clin Chim Acta; 1985 Jul; 149(2-3):105-15. PubMed ID: 3928203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of kanamycin concentration in serum by substrate-labeled fluorescent immunoassay.
    DeCastro AF; Place JD; Lam CT; Patel C
    Antimicrob Agents Chemother; 1986 Jun; 29(6):961-4. PubMed ID: 3524437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of phenobarbital and phenytoin in serum by a mechanized enzyme immunoassay (EMIT) in comparison with a gas-liquid chromatographic method.
    Oellerich M; Külpmann WR; Haeckel R; Heyer R
    J Clin Chem Clin Biochem; 1977 Jun; 15(6):353-8. PubMed ID: 330795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homogeneous substrate-labeled fluorescent immunoassay for disopyramide in human serum: semi- and fully automated procedures.
    Johnson PK; Messenger LJ
    Clin Chem; 1986 Feb; 32(2):378-81. PubMed ID: 3510781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A homogeneous fluorescent immunoassay for human immunoglobulin M.
    Worah D; Yeung KK; Ward FE; Carrico RJ
    Clin Chem; 1981 May; 27(5):673-7. PubMed ID: 7014030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homogeneous substrate-labeled fluorescent immunoassay for human serum albumin.
    Patinkin J; Inbar D; Ben-Gigi C; Derfler S; Klausner Y; Fridlender B
    J Immunoassay; 1983; 4(2):159-74. PubMed ID: 6411772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of 5-(4-hydroxyphenyl)-5-phenylhydantoin to the discrepancy between phenytoin analyses by EMIT and high-pressure liquid chromatography.
    Sawchuk RJ; Matzke GR
    Ther Drug Monit; 1984; 6(1):97-103. PubMed ID: 6369645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results by fluorescent immunoassay for phenytoin compared with those by enzyme immunoassay, liquid chromatography, and discrete analysis (Dupont aca).
    Gonzalez G; Cid-Amador A; Steele B; Castro A
    Clin Chem; 1982 Jul; 28(7):1494-6. PubMed ID: 7044616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum creatinine concentration and the discrepancy between enzyme multiplied immunoassay technique and gas-liquid chromatographic phenytoin levels.
    Apple FS; Walker FC; Dietzler DN
    Ann Clin Lab Sci; 1983; 13(5):385-92. PubMed ID: 6357047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolite and matrix interference in phenytoin immunoassays.
    Rainey PM; Rogers KE; Roberts WL
    Clin Chem; 1996 Oct; 42(10):1645-53. PubMed ID: 8855149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference in immunoassay measurements of total and free phenytoin in uremic patients: a reappraisal.
    Roberts WL; Rainey PM
    Clin Chem; 1993 Sep; 39(9):1872-7. PubMed ID: 8375063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.